Champions Oncology (CSBR) EBITDA Margin (QoQ) (2010 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -211.00 |
| Jan 31, 2026 | -290.00 |
| Oct 31, 2025 | 500.00 |
| Jul 31, 2025 | 1,248.00 |
| Apr 30, 2025 | -4,265.00 |
| Jan 31, 2025 | 2,098.00 |
| Oct 31, 2024 | -403.00 |
| Jul 31, 2024 | 1,139.00 |
| Apr 30, 2024 | 1,951.00 |
| Jan 31, 2024 | -455.00 |
| Oct 31, 2023 | 342.00 |
| Jul 31, 2023 | -103.00 |
| Apr 30, 2023 | -4.00 |
| Jan 31, 2023 | -1,929.00 |
| Oct 31, 2022 | 212.00 |
| Jul 31, 2022 | 35.00 |
| Apr 30, 2022 | -871.00 |
| Jan 31, 2022 | 406.00 |
| Oct 31, 2021 | 379.00 |
| Jul 31, 2021 | 458.00 |